· Desk editor: Nadia Hassan · · Single source ·Updated

New study questions malaria antibody use in infants

Researchers presented new findings Thursday at a medical meeting regarding the combination of a monoclonal antibody and vaccine for malaria prevention in babies.

Study raises doubts about combining vaccine, monoclonal antibody to protect against malaria
File photo Study raises doubts about combining vaccine, monoclonal antibody to protect against malaria Photo: STAT

Antibody interferes with vaccine response

Scientists tested the L9LS antibody in infants living in Mali during a six-month transmission season. The treatment showed 78 percent effectiveness against the parasite compared to a placebo group. However, the study found that this antibody reduced vaccine-generated antibody levels by 20 to 30 percent. This drop occurred when the monoclonal was given alongside the R21 malaria vaccine dose.

Plans shift to older age groups

According to Robert Seder from the National Institute of Allergy and Infectious Diseases, research groups intend to prioritize other populations initially. He suggested researchers revisit infant studies after approving the drug for older children or adults. The infection killed about 610,000 people in 2024 with most victims being children under five years old. Current vaccines require multiple doses starting at five months of age to provide long-term protection.

Costs and logistics remain challenges

Kassoum Kayentao from Mali's University of Sciences noted that a single shot covers peak transmission periods in Sahelian regions. Monoclonal antibodies are comparatively costly though efforts exist to lower the price for each dose before pivotal trials begin. Public health officials must weigh advantages and disadvantages while considering limited funding for diseases affecting poor countries.

Reported by one outlet

Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.

Reported by

1 independent outlet. Headline as published. Links open the original report.